Christian S. Schade, President & CEO at Aprea Therapeutics, Inc. (APRE), bought 6,000 shares at $15.00 ($90K) on 2019-10-07, disclosed to the SEC on 2019-10-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 1,000 | $15K | 16.7% |
| 2 | $15.00 | 5,000 | $75K | 83.3% |
| Total | $15.00 avg | 6,000 | $90K | 100% |
| Filing → |
| IART | SELL | 2018-03-06 | $1.7M | — | Filing → |
| IART | SELL | 2016-05-05 | $1.1M | — | Filing → |
| IART | SELL | 2014-02-28 | $353K | — | Filing → |